CareDx Announces KOAR Data Linking AlloSure Kidney to Higher Graft-Outcome Risk
CareDx said new KOAR data presented at ASN Kidney Week 2026 linked elevated AlloSure Kidney to nearly threefold higher risk of adverse graft outcomes among patients with borderline rejection or TCMR.